PACOR, SABRINA
 Distribuzione geografica
Continente #
NA - Nord America 12.866
EU - Europa 7.801
AS - Asia 5.693
SA - Sud America 654
Continente sconosciuto - Info sul continente non disponibili 501
AF - Africa 174
OC - Oceania 18
Totale 27.707
Nazione #
US - Stati Uniti d'America 12.674
SG - Singapore 2.082
PL - Polonia 1.835
CN - Cina 1.476
IT - Italia 1.118
SE - Svezia 1.024
DE - Germania 952
UA - Ucraina 714
VN - Vietnam 563
BR - Brasile 513
HK - Hong Kong 497
RU - Federazione Russa 404
GB - Regno Unito 374
FR - Francia 334
KR - Corea 327
FI - Finlandia 322
TR - Turchia 237
NL - Olanda 150
BD - Bangladesh 125
BG - Bulgaria 125
IE - Irlanda 124
IN - India 100
CA - Canada 93
CH - Svizzera 54
MA - Marocco 54
BE - Belgio 53
MX - Messico 50
AR - Argentina 48
BY - Bielorussia 43
JP - Giappone 43
ES - Italia 39
ZA - Sudafrica 38
IQ - Iraq 32
ID - Indonesia 28
AT - Austria 27
PK - Pakistan 26
VE - Venezuela 20
KE - Kenya 19
UZ - Uzbekistan 19
SN - Senegal 18
CO - Colombia 17
EC - Ecuador 17
PH - Filippine 17
RO - Romania 17
AU - Australia 14
BA - Bosnia-Erzegovina 14
CZ - Repubblica Ceca 13
AE - Emirati Arabi Uniti 12
CL - Cile 12
PE - Perù 11
TH - Thailandia 11
EG - Egitto 10
JO - Giordania 10
LT - Lituania 10
PT - Portogallo 10
HR - Croazia 9
MY - Malesia 9
TT - Trinidad e Tobago 9
EU - Europa 8
HN - Honduras 8
IL - Israele 8
IR - Iran 8
KZ - Kazakistan 8
RS - Serbia 8
SA - Arabia Saudita 8
HU - Ungheria 7
JM - Giamaica 7
PY - Paraguay 7
CR - Costa Rica 6
OM - Oman 6
UY - Uruguay 6
DZ - Algeria 5
GA - Gabon 5
TN - Tunisia 5
TW - Taiwan 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GE - Georgia 4
KG - Kirghizistan 4
LB - Libano 4
NP - Nepal 4
NZ - Nuova Zelanda 4
SI - Slovenia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
BB - Barbados 3
CI - Costa d'Avorio 3
GR - Grecia 3
LV - Lettonia 3
NO - Norvegia 3
PR - Porto Rico 3
AO - Angola 2
BH - Bahrain 2
BO - Bolivia 2
DK - Danimarca 2
DM - Dominica 2
LA - Repubblica Popolare Democratica del Laos 2
ML - Mali 2
MN - Mongolia 2
Totale 27.187
Città #
Warsaw 1.693
Singapore 1.244
Ashburn 1.221
Ann Arbor 1.188
Woodbridge 1.067
Houston 865
Fairfield 856
Chandler 700
San Jose 678
Jacksonville 627
Hong Kong 485
Dallas 466
Wilmington 460
Hefei 424
Seattle 368
Trieste 356
Beijing 350
Seoul 322
Cambridge 281
Council Bluffs 275
Princeton 229
Boardman 227
Columbus 207
Izmir 194
Chicago 181
Los Angeles 169
Ho Chi Minh City 163
Hanoi 132
Sofia 125
Dublin 122
Lauterbourg 121
Dearborn 120
Zgierz 116
The Dalles 115
Santa Clara 109
Moscow 107
Helsinki 91
Buffalo 89
Milan 88
Frankfurt am Main 82
New York 79
London 73
Düsseldorf 69
San Diego 58
Munich 56
Amsterdam 51
Phoenix 51
São Paulo 50
Brussels 48
Casablanca 44
Guangzhou 39
Bern 37
Tokyo 35
Porto Alegre 34
Falls Church 33
Orem 33
Brooklyn 32
Shanghai 32
North Bergen 29
Atlanta 28
Da Nang 28
Bremen 25
Haiphong 25
Mestre 25
Redwood City 25
Montreal 23
Stockholm 23
Denver 21
Des Moines 21
Norwalk 21
Rio de Janeiro 21
Tianjin 21
Turku 21
Verona 21
Kunming 20
Miano 20
Nanjing 20
Nuremberg 20
Johannesburg 19
Rome 19
Washington 19
Dakar 18
Dong Ket 18
Toronto 18
Sacile 17
San Francisco 17
Tashkent 17
Vienna 17
Grafing 16
Jinan 16
Mexico City 16
Nairobi 16
Ottawa 16
Roubaix 15
Wroclaw 15
Chennai 14
Paris 14
Redmond 14
Redondo Beach 14
Baghdad 13
Totale 18.383
Nome #
[1,2,4]Triazolo[1,5-c]pyrimidines as Tools to Investigate A3 Adenosine Receptors in Cancer Cell Lines 629
Arabica coffee extract shows antibacterial activity against Staphylococcus epidermidis and Enterococcus faecalis and low toxicity towards a human cell line 542
Biofilms from Klebsiella pneumoniae: Matrix Polysaccharide Structure and Interactions with Antimicrobial Peptides 523
Effects of gold nanoparticles, protected by self-assembling mixtures of ligands, on eukaryotic cells and model membranes 478
Effects of Two Fullerene Derivatives on Monocytes and Macrophages 476
New aspects of the structure and mode of action of the human cathelicidin LL-37 revealed by the intrinsic probe p-cyanophenylalanine 420
HIV Protease Inhibitors Apoptotic Effect in SH-SY5Y Neuronal Cell Line 402
D-BMAP18 antimicrobial peptide is active In Vitro, resists to pulmonary proteases but loses its activity in a murine model of Pseudomonas aeruginosa lung infection 391
Insights on the morphology and biological activity of gold nanoparticles protected by self-assembling mixtures of ligands 384
Gold nanoparticles with patterned surface monolayers for nanomedicine: current perspectives 369
Membrane-active antimicrobial peptide identified in Rana arvalis by targeted DNA sequencing 345
The human cathelicidin LL-37 - A pore-forming antibacterial peptide and host-cell modulator 335
Analysis of the cytotoxicity of synthetic antimicrobial peptides on mouse leucocytes: implications for systemic use. 319
Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity. 316
Role of the Escherichia coli SbmA in the antimicrobial activity of proline-rich peptides. 299
Mixed Fluorinated/Hydrogenated Self-Assembled Monolayer-Protected Gold Nanoparticles: In Silico and In Vitro Behavior 295
Apoptotic pathways of U937 leukemic monocytes investigated by infrared microspectroscopy and flow cytometry 285
Antifungal Activity of Amphotericin BConjugated to Carbon Nanotubes 272
Identification and functional characterization of the astacidin family of proline-rich host defence peptides (PcAst) from the red swamp crayfish (Procambarus clarkii, Girard 1852) 262
Infrared microspectroscopy of live cells in microfluidic devices (MD-IRMS): Toward a powerful label-free cell-based assay 253
Primate beta-defensins--structure, function and evolution. 252
Optimization of microfluidic systems for IRMS long term measurement of living cells 250
Antitumor action of mer-trichlorobis(dimethyl sulfoxide)aminoruthenium(III) (BBR2382) in mice bearing Lewis lung carcinoma 249
The marine toxin palytoxin induces necrotic death in HaCaT cells through a rapid mitochondrial damage 249
Antimetastatic Action and Lymphocyte Activation by the Modified Lysozyme Lyso-M-PEG in Mice with Mca Mammary Carcinoma 248
Native oligomerization determines the mode of action and biological activities of human cathelicidin LL-37 246
Dual mode of action of Bac7, a proline-rich antibacterial peptide 245
Cellular Internalization and Cytotoxicity of the Antimicrobial Proline-rich Peptide Bac7(1-35) in Monocytes/Macrophages, and its Activity Against Phagocytosed Salmonella Typhimurium 245
Chemical, biological and antitumor properties of ruthenium(II) complexes with dimethylsulfoxide 244
Effect of targeted minimal sequence variations on the structure and biological activities of the human cathelicidin LL-37 244
Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK 243
Synthetic antimicrobial peptides designed from sequence templates 242
Galectin-1 in cartilage: expression and influence on chondrocytes growth and interaction with ECM components 242
Structure dependence of biological activities for primate cathelicidins. 242
Response of MCa mammary carcinoma to cisplatin and to Na[trans-RuCl4(DMSO)(Im)]. 241
Multivalent, mixed self-assembled monolayer protected gold nanoparticles: from design to biological application 241
Antitumor properties of ruthenium(II)-dimethylsulfoxide complexes in the Lewis lung carcinoma system 238
Photobiomodulation therapy promotes in vitro wound healing in nicastrin KO HaCaT cells 236
Ruthenium(III) complexes as antineoplastic agents. 234
Antimetastatic action and lymphocyte activation by the modified lysozyme mPEG-Lyso in mice with MCa mammary carcinoma 234
Antitumour properties of dimethylsulphoxide ruthenium (II) complexes in theLewis lung carcinoma system. 233
trans-Ru(II)dimethylsulfoxides: antineoplastic action on mouse tumors 231
The antimetastatic drug NAMI-A potentiates the phenylephrine-induced contraction of aortic smooth muscle cells and induces a transient increase in systolic blood pressure 231
Computational and experimental investigation on the morphology and biological activity of gold nanoparticles protected by self-assembling mixtures of ligands 231
Tumor inhibition and effects on host survival time by rutheniumIII andrhodiumIII complexes with dimethylsulphoxide ligands. 228
Antineoplastic effects of mer-RuCl3(DMSO)2(NH3) against murine tumors: comparison with cisplatin and with ImH[RuIm2Cl4]. 228
Antimetastatic action and toxicity on healty tissues of Na[trans-RuCl4(DMSO)Im] in the mouse. 221
Antimetastatic action and toxicity on healthy tissues ofNa[trans-RuCl4(DMSO)Im] in the mouse. 219
Primate cathelicidin orthologues display different structures and membrane interactions 219
COMPLESSI DI Ru(III) COME AGENTI ANTINEOPLASTICI 216
Rapid and reliable detection of antimicrobial peptide penetration into Gram-negative bacteria based on fluorescence quenching. 216
Efficacy of 5-FU combined to Na[trans-RuCl4(DMSO)(Im)], a novel selective antimetastatic agent, on the survival time of mice with P388 leukemia, P388/DDP subline and MCa mammary carcinoma 212
Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: effect on mode of action and cell specificity 210
Features and full reversibility of the renal toxicity of the ruthenium-based drug NAMI-A in mice 209
Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts 206
Mast cell activation by myelin through scavenger receptor. 206
Effects on APC antigen presenting cells of short-term interaction with the human human host defense peptide beta-defensin 2 206
The development of tumor-inhibiting ruthenium dimethylsulfoxide complexes 205
Study of a potential drug delivery system based on carbon nanoparticles: Effects of fullerene derivatives in MCF7 mammary carcinoma cells 204
Effects of endotoxin in mice bearing solid metastasizing tumors and treated with lysozyme hydrochloride 204
Effects of L-(adamant-2-yl)glycyl-L-alanyl-D-isoglutamine on the antitumor action of cyclophosphamide, 5-FU, cisplatin and dacarbazine on advanced carcinomas of the mouse 203
Antineoplastic action of egg-white lysozyme on the growth of MCa mammary carcinoma and TLX5 lymphoma in the CBA mouse. 201
Na[trans-RuCl4(DMSO)(Im)]*2DMSO - antimetastatic ruthenium agent 200
Fabrication of a microfluidic platform for investigating dynamic biochemical processes in living samples by FTIR microspectroscopy 200
Antineoplastic action of p-(3-methyl-1-triazeno) benzoic acid potassium salt, monomethylderivative of the antimetastatic compound DM-COOK 198
Cathelicidins—a rich seam of antimicrobial peptides waiting for exploitation 196
Effects of trans-RuCl2 (DMSO)4 on B16 melanoma in mice. 196
Chemical, biological and antitumor properties of ruthenium-dimethylsulfoxide complexes 196
Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data 194
Bacillus cereus cell and spore properties as influenced by the micro-structure of the medium 193
Stimulation of GALT and Activation of Mesenteric Lymphonode Lymphocytes by a Modifìed Iysozyme in CBA Mice with Mca mammary carcinoma 190
Profiling the molecular mechanism of fullerene cytotoxicity on tumor cells by RNA-seq 190
DON'T JUDGE A BOOK BY ITS COVER: JANUS AND STRIPED SAM-PROTECTED GOLD NANOPARTICLES AT THE NANO-BIO INTERFACE 190
Antitumor effect of some rhodium(I) derivatives on MCa mammary carcinoma 189
Effects of ruthenium complexes on experimental tumors: irrelevance of cytotoxicity for metastasis inhibition 187
Biological and technological evaluation of PVC containers for human blood and blood components 186
Synchrotron radiation infrared microspectroscopy of single living cells in microfluidic devices: Advantages, disadvantages and future perspectives 186
Artificial beta-defensin based on a minimal defensin template 185
Fragments of the nonlytic proline-rich antimicrobial peptide Bac5 kill Escherichia coli cells by inhibiting protein synthesis 185
Na[trans-RuCl4(DMSO)Im], a metal complex of ruthenium with antimetastatic properties 180
Cytofluorimetric analysis of gut-intraepitelial and mesenteric lymph node lymphocytes of tumour bearing mice fed with egg-white lysozyme 179
Tumour metastatic potential after treatment with selective antimetastatic drugs 178
Recovery of lymphocyte CD4+:CD8+ ratio in patients treated with lysozyme 175
Lysozyme induced recovery of the response to ConA on mononuclear cells harvested from mice bearing MCa mammary carcinoma 174
Structure-activity relationship study on Bac7(1-35), a synthetic fragment of the Pro-rich antibacterial peptide Bac7 171
Designing New Hybrid Antibiotics: Proline-Rich Antimicrobial Peptides Conjugated to the Aminoglycoside Tobramycin 168
Modification of growth of MCa mammary carcinoma of CBA mouse by new adamantylpeptides 167
The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation. 166
Hydrogels based on methylated-alginates as a platform to investigate the effect of material properties on cell activity. The role of material compliance 165
Elastase-Activated Antimicrobial Peptide for a Safer Pulmonary Treatment of Cystic Fibrosis Infections 164
Design, antimicrobial activity and mechanism of action of Arg-rich ultra-short cationic lipopeptides 161
Infrared microspectroscopy of biochemical response of living cells in microfabricated devices 160
Effects of two pyridinalalkyliminerhodium(I) complexes in mice bearing MCamammary carcinoma. 159
Mechanism of tumor inhibition by the metal complex trans-RuCl2(dimethylsulphoxide)4 159
Water soluble ruthenium(III)-dimethyl sulfoxide complexes: chemical behaviour and pharmacological properties 158
Cytofluorimetric analysis of gut-intraepithelial and mesenteric lymph nodelymphocytes of tumour bearing mice fed with egg-white lysozyme. 156
Effects of the Ru(III) complexes mer-RuCl3(DMSO)2Im and Na[trans-RuCl4(DMSO)Im] on solid mouse tumors. 151
Effects of some ruthenium chelates on MCa mammary carcinoma and on TLX5 lymphoma in mice 149
Influence of agar content on the growth parameters of Bacillus cereus. 147
Intra-tumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and TIL recruitment. 144
Totale 23.891
Categoria #
all - tutte 75.218
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.218


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.504 0 0 123 230 32 137 80 50 172 188 108 384
2022/20232.081 210 287 161 314 188 363 7 179 215 20 78 59
2023/20241.084 97 70 73 71 108 71 163 221 22 29 91 68
2024/20253.079 49 117 196 282 276 288 272 168 390 361 304 376
2025/20267.761 705 608 801 653 647 674 1.118 244 766 950 359 236
2026/2027870 228 403 239 0 0 0 0 0 0 0 0 0
Totale 27.707